L1 cell adhesion molecule (L1CAM) is a strong predictor for locoregional recurrences in cervical cancer
Open Access
- 18 September 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (50) , 87568-87581
Abstract
L1 cell adhesion molecule (L1CAM) is a strong predictor for locoregional recurrences in cervical cancer L1 cell adhesion molecule (L1CAM) is a strong predictor for locoregional recurrences in cervical cancerKeywords
This publication has 53 references indexed in Scilit:
- L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter EvaluationJNCI: Journal of the National Cancer Institute, 2013
- An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor ResistanceClinical Cancer Research, 2013
- L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survivalDiagnostic Pathology, 2012
- Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activationAnnals of Oncology, 2012
- A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma modelExperimental & Molecular Medicine, 2012
- The role of human papillomavirus type 16 E6/E7 oncoproteins in cervical epithelial-mesenchymal transition and carcinogenesisOncology Letters, 2011
- L1CAM protein expression is associated with poor prognosis in non-small cell lung cancerMolecular Cancer, 2011
- Up‐regulation of L1CAM is linked to loss of hormone receptors and E‐cadherin in aggressive subtypes of endometrial carcinomasThe Journal of Pathology, 2009
- REporting recommendations for tumour MARKer prognostic studies (REMARK)European Journal of Cancer, 2005
- Prognostic relevance of TGF‐β1 and PAI‐1 in cervical cancerInternational Journal of Cancer, 2004